Exciting breakthrough in search for neurodegenerative disease treatments
2013-04-11
(Press-News.org) A significant breakthrough has been made by scientists at The University of Manchester towards developing an effective treatment for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's.
Researchers at the Manchester Institute of Biotechnology have detailed how an enzyme in the brain interacts with an exciting drug-like lead compound for Huntington's Disease to inhibit its activity. Their findings demonstrate that it can be developed as an effective treatment for neurodegenerative diseases. The research is published in the journal Nature.
Working with colleagues at the University of Leicester and the University of Lisbon in Portugal, the researchers identified the molecular structure of the enzyme kynurenine 3-monooxygense (KMO), which is found in the human brain. It took five years for the team to establish the crystal structure of KMO – the first time it's ever been done.
The scientists then studied how the compound UPF 648 binds incredibly tightly to the enzyme to act as an inhibitor. Previous studies with animal models of neurodegenerative disease have showed that switching off the enzyme activity through drug binding should be effective in the treatment of brain disorders.
Professor Nigel Scrutton who led the study said: "UPF 648 works very well as an inhibitor of enzyme activity. However, in its current form it does not pass into the brain from the blood. The search is now on for related compounds that can both inhibit the enzyme and pass into the brain."
He continues: "Our research detailing the molecular structure of the enzyme now enables a search for new KMO inhibitors that are able to cross the blood-brain barrier. This provides real hope for developing drug therapies to target neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's diseases."
Dr Flaviano Giorgini, the team's neurogeneticist from the University of Leicester, said: "This is a big move forward for the development of new KMO inhibiting drugs. It is hoped that such compounds may ultimately be tested in clinical trials and prove beneficial for patients."
The findings from this research will now be used in the search for more effective treatments for Huntington's Disease.
Professor Sarah Tabrizi is the head of the Huntington's disease research team at University College London's Institute for Neurology. Commenting on the research she says: "Unlocking the crystal structure of KMO is a real boost to our efforts to find treatments for this devastating disease. It provides a solid basis for the optimisation of inhibitor drugs like UPF 648 that are being developed by the global Huntington's disease research community. KMO is one of our top drug targets, and the crystal structure is a significant step along our roadmap to clinical trials of KMO inhibitors in patients."
Cath Stanley, Chief Executive of the Huntington's Disease Association also welcomed the findings: "This research is a really exciting piece of the jigsaw that enables us to understand a little more and takes us a step closer to being able to provide an effective treatment for Huntington's Disease."
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2013-04-11
A new study suggests that surgery for appendicitis that uses a pinhole incision through the navel may be a feasible alternative to traditional appendectomies. Published early online in the British Journal of Surgery, the findings indicate that larger studies to test the potential of the procedure are warranted.
An experimental, minimally invasive, and scarless surgical procedure for appendicitis called transgastric appendicectomy avoids the use of external incisions and causes less pain than traditional appendectomies. Through the insertion of a needle, an endoscope is ...
2013-04-11
VIDEO:
CLARITY provided this 3D view showing a thick slice of a mouse brain's memory hub, or hippocampus. It reveals a few different types of cells: Projecting neurons (green), connecting interneurons...
Click here for more information.
Slicing optional. Scientists can now study the brain's finer workings, while preserving its 3-D structure and integrity of its circuitry and other biological machinery.
A breakthrough method, called CLARITY, developed by National Institutes ...
2013-04-11
STANFORD, Calif. — Combining neuroscience and chemical engineering, researchers at Stanford University have developed a process that renders a mouse brain transparent. The postmortem brain remains whole — not sliced or sectioned in any way — with its three-dimensional complexity of fine wiring and molecular structures completely intact and able to be measured and probed at will with visible light and chemicals.
The process, called CLARITY, ushers in an entirely new era of whole-organ imaging that stands to fundamentally change our scientific understanding of the most-important-but-least-understood ...
2013-04-11
STANFORD, Calif. — Do the brains of different people listening to the same piece of music actually respond in the same way? An imaging study by Stanford University School of Medicine scientists says the answer is yes, which may in part explain why music plays such a big role in our social existence.
The investigators used functional magnetic resonance imaging to identify a distributed network of several brain structures whose activity levels waxed and waned in a strikingly similar pattern among study participants as they listened to classical music they'd never heard ...
2013-04-11
Hunter-gatherers living in glacial conditions produced pots for cooking fish, according to the findings of a pioneering new study led by the University of York which reports the earliest direct evidence for the use of ceramic vessels.
Scientists from the UK, the Netherlands, Sweden and Japan carried out chemical analysis of food residues in pottery up to 15,000 years old from the late glacial period, the oldest pottery so far investigated. It is the first study to directly address the often posed question "why humans made pots?" The research is published in Nature.
The ...
2013-04-11
STANFORD, Calif. — Mining the records of routine interactions between patients and their care providers can detect drug side effects a couple of years before an official alert from the U.S. Food and Drug Administration, a Stanford University School of Medicine study has found.
The study, led by Nigam Shah, MBBS, PhD, assistant professor of medicine, will be published online April 10 in Nature Clinical Pharmacology and Therapeutics.
This approach is a step forward in mining patient-based information, as opposed to coded insurance reports or drug-specific databases, to ...
2013-04-11
Half of all formal patient complaints made in Australia to health ombudsmen concern just 3% of the country's doctors, with 1% accounting for a quarter of all complaints, finds research published online in BMJ Quality & Safety.
Doctors complained about more than three times are highly likely to be the subject of a further complaint - and often within a couple of years - the findings show.
The problem is unlikely to be confined to Australia, warn commentators, who point out that while regulators often know about these problem doctors, patients usually don't.
The researchers ...
2013-04-11
Rates of surgery to correct childhood squint in England have tumbled over the past 50 years, finds research published online in the British Journal of Ophthalmology.
But there's still a fivefold difference between the areas with the lowest and highest rates of the procedure, similar to the wide variations in tonsil removal, and it's not clear why, say the authors.
Squint (strabismus) is one of the most common eye problems in children, with a prevalence of between 2% and 5%. Risk factors include family history, low birthweight, premature birth, being born to an older ...
2013-04-11
A research team of Inserm, CNRS and MDC lead by Michael Sieweke of the Centre d'Immunologie de Marseille Luminy (CNRS, INSERM, Aix Marseille Université) and Max Delbrück Centre for Molecular Medicine, Berlin-Buch, today revealed an unexpected role for hematopoietic stem cells: they do not merely ensure the continuous renewal of our blood cells; in emergencies they are capable of producing white blood cells "on demand" that help the body deal with inflammation or infection. This property could be used to protect against infections in patients undergoing bone marrow transplants, ...
2013-04-11
For the first time, scientists have been able to predict how much pain people are feeling by looking at images of their brains, according to a new study led by the University of Colorado Boulder.
The findings, published today in the New England Journal of Medicine, may lead to the development of reliable methods doctors can use to objectively quantify a patient's pain. Currently, pain intensity can only be measured based on a patient's own description, which often includes rating the pain on a scale of one to 10. Objective measures of pain could confirm these pain reports ...
LAST 30 PRESS RELEASES:
[Press-News.org] Exciting breakthrough in search for neurodegenerative disease treatments
